Torrent Pharmaceuticals (TORNTPHARM) — Board Meeting

📢 Key Event
Board approved Q1 FY27 results showing 55% revenue growth and 3% net profit increase.

🔄 What Changed
Operating EBITDA grew 61% YoY to ₹1,664 crores with 33.8% margin, and exceptional items of ₹21 crores were recorded due to JB Pharma acquisition and amalgamation.

🔮 What's Next
The company emphasized sustained growth in key markets and financial resilience, though no explicit future targets or deadlines were provided.

💡 Investor Takeaway
Shareholders see strong top-line momentum and improving profitability, supported by regional diversification and robust balance sheet metrics.

Torrent Pharmaceuticals reported consolidated revenue of ₹4,921 crores (+55% YoY) and net profit of ₹566 crores (+3% YoY) for Q1 FY27, driven by strong growth in India, Brazil, and the US markets, with operating EBITDA at ₹1,664 crores (+61% YoY) and a 33.8% margin. The Board approved results on July 30, 2026, following a limited review by SR & Co. LLP, and disclosed exceptional items including Rs 21 crores from the JB Pharma acquisition and amalgamation. The company highlighted regional momentum and financial resilience, with debt-to-equity at 0.78 and security coverage exceeding 110% of debenture principal.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does the 55% revenue growth compare to peers in the domestic pharma sector?" "What is the expected timeline for full integration of JB Pharma post-acquisition?" "How will the Rs 21 crores exceptional items impact future cash flow guidance?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 30 July 2026

PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document AJANTPHARM Ajanta Pharma Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action AYMSYNTEX AYM Syntex Limited Announcement GILLETTE Gillette India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.